Delivery Order SPE2DB20D7066-SPE2DB24FC2UH

Award Date 9/25/24
Potential Completion Date 9/26/24
Potential Value $4.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RABAVERT RABIES VACC W-DILUENTS, a vaccine product, with a ceiling value of $10,479.00 and a period of performance through May 19, 2025. The contract is a firm fixed price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of RABAVERT rabies vaccine with diluents, with a ceiling value of $1,105.74 and a completion date of June 14, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,158.18 and provides for the delivery of RABAVERT rabies vaccine with diluents. The contract has a firm-fixed price pricing type and runs through August 2, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RABAVERT rabies vaccine with diluents. The contract has a ceiling value of $11,526.90 and a period of performance through May 1, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open competition. This delivery order is part of a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RABAVERT rabies vaccine with diluents, with a ceiling value of $2,095.80 and a period of performance through March 11, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RABAVERT rabies vaccine with diluents, with a ceiling value of $13,890.24 and a completion date of July 3, 2025. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RABAVERT rabies vaccine with diluents. The contract, valued at $54,048.40, has a firm fixed price and an ultimate completion date of August 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RABAVERT rabies vaccine with diluents. The contract has a ceiling value of $2,514.96 and is a firm fixed-price delivery order, with a period of performance ending on June 23, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RABAVERT rabies vaccine with diluents. The contract has a firm fixed price of $2,685.68 and a completion date of June 4, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle for the Defense...
This is a delivery order contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of RABAVERT rabies vaccine with diluents, with a ceiling value of $1,585.08 and a period of performance through October 25, 2022. This contract is a Firm Fixed Price, Delivery Order type, with no set-aside designation. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract...
  • SPE2DB20D7066
    Indefinite Delivery Contract
  • SPE2DB20D7066-SPE2DB24FC2UH
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of RABAVERT rabies vaccine with diluents. The contract has a ceiling value of $4,825.75 and is set to be completed by September 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. As a leading supplier of pharmaceutical and medical products to various government agencies, Amerisourcebergen leverages its extensive supply chain network to deliver critical care materials, specialty medications, and other essential medical supplies to federal healthcare providers, including military treatment facilities and veterans' hospitals.

Generated 12/25/24, 9:13 AM